Shasun Pharmaceuticals Limited (Formerly known as 'Shasun Chemicals and Drugs Ltd.,') was incorporated in 1976 and is headquartered in Chennai, India. It manufactures active pharmaceutical ingredients (APIs), their intermediates and enteric coating excipients with a significant presence in some key generics. Shasun has created a strong product portfolio, building on its R & D Expertise, regulatory capabilities and multi scale production capacities. Shasun has also emerged as a key player in various service segments in the pharmaceutical field besides APIs and intermediaries, and is strengthening its offer of contract research, custom synthesis, contract manufacturing and contract formulation services to clients.
Today, Shasun is one of the largest producers of Ibuprofen worldwide. The company offers derivatives of Ibuprofen like Ibuprofen Sodium, Ibuprofen Lysinate and S+Ibuprofen. It is also one of the major producers of Ranitidine and Nizatidine in the world. Its products are exported to countries across North America, Europe, Asia and Latin America.
Shasun in its endeavour to become a true one-stop shop for global pharma companies, is evolving its business model to become a complete service provider, offering services right from the discovery stage to manufacturing formulations. The company has recently added finished formulations capability as forward integration, and has invested in large facility to cater to the international regulated market. It has tied up with multinational companies in the formulations space wherein it will be developing and supplying products for the US market. The recent acquisition of the business and facilities of Rhodia Pharma Solutions by Shasun's wholly owned subsidiary Shasun Pharma Solutions Ltd (SPSL), UK equipped the company to evolve as a technology based service provider than as a contract manufacturing and research provider. Its services include innovative process research and development, rapid response small scale manufacture for clinical trial supply and full scale commercial manufacture of advanced intermediates and API?s, all with seamless technology transfer with and without cGMP. The formulation unit at Puducherry has been approved by US FDA.
By integrating its facilities in India and UK, the company is trying to offer the benefits of operations in both the countries to its clients. The company has aligned its facilities so that while research can be conducted in India, development and manufacturing in kilo labs and pilot plant can be conducted either in UK or India and the optimal mix could be decided based on the regulatory, IP and cost. The company is planning to set up a multi-product pilot plant facility at Vizag, Andhra Pradesh, focusing on Contract Manufacturing Services business. In FY06, CRAMS business revenue has reached INR 3430 million.
Quality and EHS Policy
We commit to meet National/International Standards and to manufacture and supply consistent quality Active Pharmaceutical Ingredients, Excipients, Intermediates and Pharmaceutical Dosage Forms to achieve customer satisfaction.
We care, to meet changing customer expectations, to enhance our employee contributions and to develop and retain our suppliers, in order to sustain our organizational performance.
We evaluate results of our management processes, work methods, practices, controls and resources on an on-going basis, to achieve continual improvement of our systems, products and services.
We accept responsibilities, to provide conducive work environment for our employees, to reduce problems and to desist from adversely impacting our surroundings.
Environment, Health and Safety Policy
Shasun is committed to protecting the Safety, Health and well-being of its employees, the community in which we operate and the wider environment.
In achieving this aim we will:
Comply with all applicable legal and other requirements.
Operate with the principles of Responsible Care and continually strive for excellence.
Continually review and improve our processes, services and products to reduce industrial risk and impacts.
Educate, train and motivate employees to conduct their activities in a safe and environmentally responsible manner.
Use resources efficiently and minimize waste utilizing pollution prevention techniques.
Work with suppliers and partners to mutually improve EHS performance.
Integrate our sites effectively into their natural environment and local communities.